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Due to clerical errors in the original article, the authors would like to provide the following corrections.

First, the following image for Figure 1 D (Con) was incorrect:

![](10.1177_0300060520905933-fig1.jpg)

The correct image is as follows:

![](10.1177_0300060520905933-fig2.jpg)

Second, the following image for Figure 2 E platelet+DR5 was incorrect:

![](10.1177_0300060520905933-fig3.jpg)

The correct image is as follows:

![](10.1177_0300060520905933-fig4.jpg)

Third, the following image for Figure 3E TRAIL was incorrect:

![](10.1177_0300060520905933-fig5.jpg)

The correct image is as follows:

![](10.1177_0300060520905933-fig6.jpg)

Fourth, the following image for Figure 1 B platelet was incorrect:

![](10.1177_0300060520905933-fig7.jpg)

The correct image is as follows:

![](10.1177_0300060520905933-fig8.jpg)

Fifth, [Table 2](#table1-0300060520905933){ref-type="table"} contained three errors. N1 has been corrected to N0, N2 has been corrected to N1, and N3 has been corrected to N2.

###### 

Clinicopathological characteristics of 90 colon cancer patients, stratified for low and high CD62P protein expression.

![](10.1177_0300060520905933-table1)

  Clinicopathological characteristics   Totaln = 90 (%)   CD62P-lown = 32 (35.56%)   CD62P-highn = 58 (64.44%)   χ^2^-value   P-value
  ------------------------------------- ----------------- -------------------------- --------------------------- ------------ ------------
  Sex                                                                                                                         
   Male                                 50 (55.56%)       19 (21.11%)                31 (34.44%)                 0.2934       0.5881
   Female                               40 (44.44%)       13 (14.44%)                27 (30%)                                 
  Age (years)                                                                                                                 
   ≤60                                  47 (52.22%)       17 (18.89%)                30 (%)                      0.0162       0.8987
   \>60                                 43 (47.78%)       15 (16.67%)                28 (%)                                   
  Histological grade                                                                                                          
   Well differentiated                  7 (7.78%)         5 (5.56%)                  2 (2.22%)                   4.273        0.1181
   Moderately differentiated            64 (71.11%)       21 (23.33%)                43 (47.78%)                              
   Poorly differentiated                19 (21.11%)       6 (6.67%)                  13 (14.44%)                              
  Tumour stage                                                                                                                
   T1                                   7 (7.78%)         5 (5.56%)                  2 (2.22%)                   14.39        0.0024\*
   T2                                   16 (17.78%)       10 (11.11%)                6 (6.67%)                                
   T3                                   53 (58.89%)       11 (12.22%)                42 (46.67%)                              
   T4                                   14 (15.56%)       6 (6.67%)                  8 (8.89%)                                
  Nodal stage                                                                                                                 
   N0                                   39 (43.33%)       26 (28.89%)                13 (14.44%)                 32.83        \<0.0001\*
   N1                                   32 (35.56%)       5 (5.56%)                  28 (31.11%)                              
   N2                                   18 (20%)          0                          18 (20%)                                 
  Lymph nodes invasion                                                                                                        
   No                                   40 (44.44%)       29 (32.22%)                11 (%)                      36.93        \<0.0001\*
   Yes                                  50 (55.56%)       5 (5.56%)                  45 (%)                                   
  Vascular invasion                                                                                                           
   No                                   76 (%)            31 (%)                     45 (12.22%)                 5.841        0.0158\*
   Yes                                  14 (%)            1 (%)                      13 (14.44%)                              
  Clinical stage                                                                                                              
   I/II                                 37 (41.11%)       26 (28.89%)                11 (12.22%)                 33.04        \<0.0001\*
   III/IV                               53 (58.89%)       6 (6.67%)                  47 (52.22%)                              

Abbreviation: *P*-values were calculated by χ^2^-test or independent t-testing for continuous data.

\*Significant P-values: P \< 0.05.

The correct Table is given below:
